Open access
Aug 2026
Meningococcal disease epidemiology – United States, 2020–2023
Meningococcal disease incidence continued to decline during the COVID-19 pandemic but increased to above pre-COVID-19 pandemic incidence by 2023, and it will be important to continue to monitor meningococcal disease incidence, especially of serogroup Y, over the next several years.
Amy B. Rubis, Basanta R. Wagle, Shreya Khuntia et al.
· PLoS ONE · 0 citations